Colgate-Palmolive Company $CL Shares Sold by SVB Wealth LLC

Posted by Francis Steltz on May 13th, 2026

SVB Wealth LLC reduced its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 54.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,672 shares of the company’s stock after selling 10,319 shares during the quarter. SVB Wealth LLC’s holdings in Colgate-Palmolive were worth $685,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. ProShare Advisors LLC grew its position in shares of Colgate-Palmolive by 11.0% during the third quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock worth $163,681,000 after buying an additional 202,379 shares in the last quarter. Providence Capital Advisors LLC acquired a new position in shares of Colgate-Palmolive during the third quarter worth about $5,373,000. Citigroup Inc. grew its position in shares of Colgate-Palmolive by 43.7% during the third quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock worth $107,646,000 after buying an additional 409,710 shares in the last quarter. Envestnet Asset Management Inc. grew its position in shares of Colgate-Palmolive by 18.0% during the third quarter. Envestnet Asset Management Inc. now owns 800,554 shares of the company’s stock worth $63,996,000 after buying an additional 122,202 shares in the last quarter. Finally, TD Waterhouse Canada Inc. grew its position in shares of Colgate-Palmolive by 248.5% during the third quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock worth $6,909,000 after buying an additional 62,327 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $1,018,691.15. The trade was a 59.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CL shares. Jefferies Financial Group boosted their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Citigroup boosted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Weiss Ratings raised Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $99.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Evercore upped their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. Twelve analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $95.88.

Check Out Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

Shares of CL opened at $87.54 on Wednesday. The stock has a 50 day moving average price of $86.76 and a 200 day moving average price of $84.51. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The company has a market capitalization of $70.23 billion, a price-to-earnings ratio of 34.06, a price-to-earnings-growth ratio of 4.49 and a beta of 0.31. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33.

Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 earnings per share. Research analysts predict that Colgate-Palmolive Company will post 3.83 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, April 20th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.